LIFECORE BIOMEDICAL, INC. Accrued Liabilities, Current
LIFECORE BIOMEDICAL, INC. (LFCR) had Accrued Liabilities, Current of $14.11 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Accrued Liabilities, Current $14.11M.
- 2026-03-31: Accrued Liabilities, Current $13.48M.
- 2025-12-31: Accrued Liabilities, Current $17.36M; Accrued Liabilities, Current as first filed $17.73M.
- 2025-09-30: Accrued Liabilities, Current $19.84M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $14.11M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $13.48M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $17.36M 10-Q · filed 2026-08-05 | $17.73M 10-KT · filed 2026-03-16 |
| 2025-09-30 | $19.84M 10-Q · filed 2025-11-06 | |
| 2025-05-25 | $21.96M 10-KT · filed 2026-03-16 | |
| 2025-02-23 | $19.75M 10-Q · filed 2025-04-03 | |
| 2024-05-26 | $22.54M 10-KT · filed 2026-03-16 | $18.57M 10-Q · filed 2025-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |